Literature DB >> 30235970

Predictors of Response to 4-Aminopyridine in Chronic Canine Spinal Cord Injury.

Melissa J Lewis1, Eric Laber2, Natasha J Olby3,4.   

Abstract

4-Aminopyridine (4AP), a potassium channel antagonist, can improve hindlimb motor function in dogs with chronic thoracolumbar spinal cord injury (SCI); however, individual response is variable. We hypothesized that injury characteristics would differ between dogs that do and do not respond to 4AP. Our objective was to compare clinical, electrodiagnostic, gait, and imaging variables between dogs that do and do not respond to 4AP, to identify predictors of response. Thirty-four dogs with permanent deficits after acute thoracolumbar SCI were enrolled. Spasticity, motor and sensory evoked potentials (MEPs, SEPs), H-reflex, F-waves, gait scores, and magnetic resonance imaging (MRI) with diffusion tensor imaging (DTI) were evaluated at baseline and after 4AP administration. Baseline variables were assessed as predictors of response; response was defined as ≥1 point change in open field gait score. Variables were compared pre- and post-4AP to evaluate 4AP effects. Fifteen of 33 (45%) dogs were responders, 18/33 (55%) were non-responders and 1 was eliminated because of an adverse event. Pre-H-reflex threshold <1.2 mA predicted non-response; pre-H-reflex threshold >1.2 mA and Canine Spasticity Scale overall score <7 were predictive of response. All responders had translesional connections on DTI. MEPs were more common post-4AP than pre-4AP (10 vs. 6 dogs) and 4AP decreased H-reflex threshold and increased spasticity in responders. 4-AP impacts central conduction and motor neuron pool excitability in dogs with chronic SCI. Severity of spasticity and H-reflex threshold might allow prediction of response. Further exploration of electrodiagnostic and imaging characteristics might elucidate additional factors contributing to response or non-response.

Entities:  

Keywords:  canine; chronic SCI; motor neuron pool excitability; potassium channel antagonist; spasticity

Year:  2018        PMID: 30235970      PMCID: PMC6482892          DOI: 10.1089/neu.2018.5975

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  33 in total

1.  Stretch reflexes in patients with spinal cord lesions.

Authors:  J W MAGLADERY; R D TEASDALL
Journal:  Bull Johns Hopkins Hosp       Date:  1958-11

2.  Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial.

Authors:  D L Wolfe; K C Hayes; J T Hsieh; P J Potter
Journal:  J Neurotrauma       Date:  2001-08       Impact factor: 5.269

3.  High doses of 4-aminopyridine improve functionality in chronic complete spinal cord injury patients with MRI evidence of cord continuity.

Authors:  Israel Grijalva; Angélica García-Pérez; Jenaro Díaz; Sergio Aguilar; Dolores Mino; Efraín Santiago-Rodríguez; Gabriel Guizar-Sahagún; Gilberto Castañeda-Hernández; Héctor Maldonado-Julián; Ignacio Madrazo
Journal:  Arch Med Res       Date:  2010-10       Impact factor: 2.235

4.  Neuropathology of human spinal cord injury sustained in sports-related activities.

Authors:  K C Hayes; B A Kakulas
Journal:  J Neurotrauma       Date:  1997-04       Impact factor: 5.269

5.  Development of a clinical spasticity scale for evaluation of dogs with chronic thoracolumbar spinal cord injury.

Authors:  Melissa J Lewis; Natasha J Olby
Journal:  Am J Vet Res       Date:  2017-07       Impact factor: 1.156

6.  Magnetic motor evoked potentials for assessing spinal cord integrity in dogs with intervertebral disc disease.

Authors:  A M Sylvestre; J R Cockshutt; J M Parent; J D Brooke; D L Holmberg; G D Partlow
Journal:  Vet Surg       Date:  1993 Jan-Feb       Impact factor: 1.495

7.  Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model.

Authors:  Nicolas Granger; Helen Blamires; Robin J M Franklin; Nick D Jeffery
Journal:  Brain       Date:  2012-11       Impact factor: 13.501

8.  Gait scoring in dogs with thoracolumbar spinal cord injuries when walking on a treadmill.

Authors:  Natasha J Olby; Ji-Hey Lim; Kellett Babb; Kathleen Bach; Cullen Domaracki; Kim Williams; Emily Griffith; Tonya Harris; Audrey Muguet-Chanoit
Journal:  BMC Vet Res       Date:  2014-03-05       Impact factor: 2.741

9.  A Placebo-Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation.

Authors:  N J Olby; A C Muguet-Chanoit; J-H Lim; M Davidian; C L Mariani; A C Freeman; S R Platt; J Humphrey; M Kent; C Giovanella; R Longshore; P J Early; K R Muñana
Journal:  J Vet Intern Med       Date:  2015-10-31       Impact factor: 3.333

10.  Magnetic resonance imaging features of dogs with incomplete recovery after acute, severe spinal cord injury.

Authors:  Melissa J Lewis; Eli B Cohen; Natasha J Olby
Journal:  Spinal Cord       Date:  2017-10-23       Impact factor: 2.772

View more
  2 in total

1.  Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers.

Authors:  Sofia Rodríguez-Rangel; Alyssa D Bravin; Karla M Ramos-Torres; Pedro Brugarolas; Jorge E Sánchez-Rodríguez
Journal:  Sci Rep       Date:  2020-01-09       Impact factor: 4.379

Review 2.  Emerging and Adjunctive Therapies for Spinal Cord Injury Following Acute Canine Intervertebral Disc Herniation.

Authors:  Melissa J Lewis; Nicolas Granger; Nick D Jeffery
Journal:  Front Vet Sci       Date:  2020-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.